Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON36929Active, not recruiting
Randomised, double-blind trial in asphyxia neonatorum and hypoxic-ischemic encephalopathy (HIE) comparing Allopurinol with Placebo (2 arms). Primary endpoints: Severity of oxidative stress in umbilical cord and neonatal blood and S100B brain damage marker. Started Jan 2009; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON36929.